PedAM
Pediatric Disease Annotations & Medicines
| Disease | polyneuropathy |
| Phenotype | C0011860|type 2 diabetes |
| Sentences | 5 |
| PubMedID- 21887102 | In the (alpha-lipoic acid in diabetic neuropathy) aladin ii trial, subjects with type 1 and type 2 diabetes complicated by symptomatic polyneuropathy were randomly assigned for 2 years to 1200 mg, or 600 mg ala or placebo after intravenous infusion of ala or placebo. |
| PubMedID- 23565468 | Evaluation of diabetic polyneuropathy in type 2 diabetes mellitus by nerve conduction study and association of severity of neuropathy with serum sfasl level. |
| PubMedID- 21505209 | Accuracy of the neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetes. |
| PubMedID- 26184671 | In the absence of diabetic polyneuropathy, individuals with type 2 diabetes had a lower nerve density (nerve branch density: -1.10/mm(2) [95% ci -4.22 to 2.02]), nerve fibre density: -5.80/mm(2) [-8.06 to -3.54], and nerve fibre length: -4.00 mm/mm(2) [-5.93 to -2.07]) in the subbasal nerve plexus of the cornea than individuals without diabetes. |
| PubMedID- 25527522 | Cardiovascular disease predicts diabetic peripheral polyneuropathy in subjects with type 2 diabetes: a 10-year prospective study. |
Page: 1